Related Experiment Video
Updated: Jun 20, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
[Bacteria and biofilm in respiratory tract infections]
1Laboratorio Analisi Chimico-Cliniche e Microbiologiche, IRCCS Istituto Galeazzi, Dipartimento di Scienze Precliniche DISP LITA, Universita degli Studi di Milano.
Abstract:
Biofilm is a structured community of bacterial cells included in a self-produced polymeric matrix adherent to an inert or living surface. The main property of biofilm consists of making microrganisms more resistant to exogenous insults. Antibiotic therapy typically resolves symptoms determined by planktonic cells released by biofilms but is not able to eradicate and completely clear biofilm. This is why infections sustained by biofilm-producer bacteria are often recurrent, making mandatory repeated antibiotic treatments. The typical conformation of biofilm, the phenotypical and genetical features existing among the different microrganisms confer a natural resistance to a number of antimicrobials so that it is necessary to test antimicrobial activity against the microbial species itself and also against biofilm, when it is present. Comparative studies, performed on quinolones and beta-lactams, evidenced a significant activity against biofilm produced by pneumococci, haemophyli and pseudomonas as well.
Related Concept Videos
Microbiota of the Respiratory Tract
Biofilms
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia

